Search details
1.
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation.
Hematol Oncol
; 38(3): 257-265, 2020 Aug.
Article
in English
| MEDLINE | ID: mdl-32356913
2.
Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
Hematol Oncol
; 31(3): 143-50, 2013 Sep.
Article
in English
| MEDLINE | ID: mdl-23161567
3.
RE-MIND: Comparing Tafasitamab + Lenalidomide (L-MIND) with a Real-world Lenalidomide Monotherapy Cohort in Relapsed or Refractory Diffuse Large B-cell Lymphoma.
Clin Cancer Res
; 27(22): 6124-6134, 2021 11 15.
Article
in English
| MEDLINE | ID: mdl-34433649
4.
MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial.
Lancet Haematol
; 8(2): e110-e121, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33513372
5.
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.
Lancet
; 374(9700): 1512-20, 2009 Oct 31.
Article
in English
| MEDLINE | ID: mdl-19767089
6.
Identical IGHV-D-J gene rearrangement may precede the clinical onset of chronic lymphocytic leukemia by several years.
Am J Hematol
; 85(11): 868-71, 2010 Nov.
Article
in English
| MEDLINE | ID: mdl-20872553
7.
Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial.
Lancet Haematol
; 4(3): e137-e146, 2017 Mar.
Article
in English
| MEDLINE | ID: mdl-28219694
8.
Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas.
J Clin Oncol
; 34(33): 4015-4022, 2016 11 20.
Article
in English
| MEDLINE | ID: mdl-28199143
9.
The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis.
Ann Intern Med
; 139(6): 470-5, 2003 Sep 16.
Article
in English
| MEDLINE | ID: mdl-13679323
10.
Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination.
Oncologist
; 11(3): 285-91, 2006 Mar.
Article
in English
| MEDLINE | ID: mdl-16549813
11.
Splenic marginal zone lymphoma: a prognostic model for clinical use.
Blood
; 107(12): 4643-9, 2006 Jun 15.
Article
in English
| MEDLINE | ID: mdl-16493005
Results
1 -
11
de 11
1
Next >
>>